- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00731926
Effect of Antioxidant on Endurance Performance in Healthy Men
August 10, 2008 updated by: Seoul National University Hospital
Effect of Antioxidant on Endurance Performance in Healthy Men -Double Blind Randomized Placebo and Active Controlled Trial-
oligomerized litchi fruit extract may enhance the submaximal endurance exercise performance
Study Overview
Status
Completed
Conditions
Detailed Description
Regular physical exercise has many beneficial effects, but it has been reported that strenuous exercise could elevate the production of free radical and other reactive oxygen species (ROS) which eventually injure the tissues and decrease the muscle function.So many kinds of antioxidant supplementations have been tried to decrease the muscle fatigue and enhance the exercise performance.
polyphenolic flavonoids abundant in fruits and leafy vegetables have strong antioxidant effect.
oligomerized litchi fruit extract has strong antioxidant capacity and higher bioavailability compared to that of grape seed polyphenol.
The aim of this study was to determine whether oligomerized litchi fruit extract could induce endurance exercise performance more than Vit C + Vit E mixture or placebo could do.
Therefore, we designed double blind randomized controlled trial, setting the change of running time to exhaustion under submaximal treadmill test as the primary endpoint.
Study Type
Interventional
Enrollment (Actual)
69
Phase
- Phase 2
- Phase 3
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- healthy men over 20 years old non-smoker
Exclusion Criteria:
- BMI>25 or body fat>25% he who intakes the antioxidant supplement in recent 2 weeks
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
|
100mg at once twice a day for 1 month
Other Names:
|
Active Comparator: 2
|
Vitamin C 400mg + Vitamin E 160IU at once twice a day for 1 month
|
Placebo Comparator: 3
|
twice a day for 1 month
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
change of running time to exhaustion under 80% of maximal heart rate
Time Frame: 1 month
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
VO2max, anaerobic threshold
Time Frame: 1 month
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Sang-chul Lee, professor, Institute of Complementary Alternative Medicine SNUMC
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2007
Primary Completion (Actual)
January 1, 2008
Study Completion (Actual)
February 1, 2008
Study Registration Dates
First Submitted
May 20, 2008
First Submitted That Met QC Criteria
August 7, 2008
First Posted (Estimate)
August 11, 2008
Study Record Updates
Last Update Posted (Estimate)
August 12, 2008
Last Update Submitted That Met QC Criteria
August 10, 2008
Last Verified
August 1, 2008
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-0707-028-212
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Exercise Tolerance
-
Ulaş ArHacettepe UniversityCompletedExercise ToleranceTurkey
-
Tel-Aviv Sourasky Medical CenterCompletedAging | Exercise ToleranceIsrael
-
University of MinnesotaCompletedExercise Tolerance | Endothelial CellsUnited States
-
Grupo Español de Rehabilitación MultimodalUnknownSurgery | Perioperative/Postoperative Complications | Exercise ToleranceSpain
-
Federico II UniversityUnknownHeart Failure | Exercise ToleranceItaly
-
Northern Health and Social Care TrustUnknown
-
University of Sao Paulo General HospitalCompletedHeart Failure | Body Composition | Vasodilation | Muscle Strength | Exercise ToleranceBrazil
-
Pusan National UniversityMarymount University; Dong-Eui UniversityCompletedPeripheral Arterial Disease | Peripheral Artery Disease | Vascular Function | Exercise Tolerance
-
Alcon ResearchNOVARTIS BIOCIENCIAS S/ACompleted
-
PhytheaCompletedRenal Tolerance | Digestive ToleranceFrance
Clinical Trials on Oligomerized litchi fruit extract
-
Unilever R&DCompleted
-
University of California, DavisCompletedCardiovascular HealthUnited States
-
Unilever R&DLambda Therapeutic Research Ltd.Completed
-
Ratan K. ChaudhuriCompleted
-
Unilever R&DCompleted
-
Seoul St. Mary's HospitalRural Development Administration, KoreaCompletedOxidative StressKorea, Republic of
-
Florida State UniversityCompleted
-
Integrative Skin Science and ResearchSytheon Ltd.CompletedHuman MicrobiomeUnited States
-
Unilever R&DCompleted
-
Burapha UniversityCompletedBody Massage Oil From Snake Fruit | Facial Mask From Snake Fruit | Jelly From Snake FruitThailand